Who founded Genomic Vision?

Genomic Vision was founded by Aaron Bensimon, Florence Allouche in 2005.

Who are Genomic Vision's investors?

Genomic Vision's investors include Vesalius Biocapital Partners.

Genomic Vision

Founded 2005 · 10 employees on LinkedIn · 1 known investors

Find your way into Genomic Vision

Each arrow is one introduction. Sign up to fill in the first one.

411 people can intro you to Florence

Ask Sharon Tan to introduce you to Florence Allouche

You →Sharon · together at NLS Pharmaceutics AG →Florence

61 people can intro you to Aaron

Ask Jamie Chen to introduce you to Aaron Bensimon

You →Jamie · together at Genomic Vision →Aaron

Your email: who you already know at Genomic Vision, and who your contacts know
2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Genomic Vision team
Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Genomic Vision is a genome analysis company whose Molecular Combing technology characterizes DNA at single-molecule resolution for quality control in bioproduction and cell and gene therapy, as well as for drug discovery research. It serves pharmaceutical, biotech, and research organizations developing gene therapies and studying DNA replication.

AI & Machine Learning Biotech Medical Devices

Founders & leadership

Genomic Vision was founded in 2005 by Aaron Bensimon and Florence Allouche.

Aaron Bensimon Chairman of the Executive BoardAaron Bensimon is Chairman of the Executive Board at Genomic Vision, a genome analysis company. He brings biotechnology industry experience and expertise in business development, life sciences, and molecular biology.

Florence Allouche Chairman of the Supervisory BoardFlorence Allouche holds a Doctor of Pharmacy and MBA from HEC Paris. She founded and led AP-HP's Tech Transfer Office for 16 years, during which she helped establish over 75 biotech and medtech startups. She co-founded SparingVision, a clinical-stage gene therapy company, serving as President through Series B, and is currently CEO and co-founder of DeltaWave, an AI infrastructure startup for molecular research.

Investors · 1

Vesalius Biocapital Partnerslisted by Vesalius Biocapital PartnersLuxembourg · $11M

Founder mafia

4 people who came through Genomic Vision went on to found or lead other companies.

David DelbourgoHead of Sales and MarketingFounded WhiteLab Genomics Julien CottineauSenior Application ScientistFounded WhiteLab Genomics Sylvain BerlemontData ScientistFounded Spotlight Medical Isabelle RacamierChair of the Supervisory BoardFounded EsoCap Biotech

Frequently asked questions

What does Genomic Vision do?: Genomic Vision is a genome analysis company whose Molecular Combing technology characterizes DNA at single-molecule resolution for quality control in bioproduction and cell and gene therapy, as well as for drug discovery research. It serves pharmaceutical, biotech, and research organizations developing gene therapies and studying DNA replication.
Who founded Genomic Vision?: Genomic Vision was founded by Aaron Bensimon, Florence Allouche in 2005.
Who are Genomic Vision's investors?: Genomic Vision's investors include Vesalius Biocapital Partners.